Global Virus-like Particle Market Research Report 2026(Status and Outlook)
Virus-like particles (VLPs) are artificial protein structures with a similar overall structure to their corresponding native viruses. They resemble viruses with self-assembly properties but lose original infectious ability due to genome modifications. VLPs are symmetrically built from hundreds of coat proteins, which can be genetically engineered to present a regular arrangement of epitope chains on the desired positions of the outer surface. Compared with monomeric or oligomeric protein carriers, VLPs are able to provide not only a higher density of foreign proteins per particle but also support a distinctive three-dimensional conformation, which is especially important for the presentation of conformational epitopes. Currently, VLPs have been recognized as one of the most promising and extensively studied molecular carriers or nanoparticles, for a variety of applications.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Virus-like Particle market size was estimated at USD 381.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Virus-like Particle market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Virus-like Particle market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Virus-like Particle market.
Global Virus-like Particle Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
The Native Antigen Company
Creative BioStructure
Creative Biolabs
Leadgene Biomedical
Abcam
ACROBiosystems
Gentarget
VectorBuilder
Market Segmentation (by Type)
E. coli
Yeast
Insect Cells
Others
Market Segmentation (by Application)
Vaccine
Therapeutics
Bioimaging
Others
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Virus-like Particle Market
Overview of the regional outlook of the Virus-like Particle Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Virus-like Particle Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Virus-like Particle, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Virus-like Particle market size was estimated at USD 381.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Virus-like Particle market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Virus-like Particle market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Virus-like Particle market.
Global Virus-like Particle Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
The Native Antigen Company
Creative BioStructure
Creative Biolabs
Leadgene Biomedical
Abcam
ACROBiosystems
Gentarget
VectorBuilder
Market Segmentation (by Type)
E. coli
Yeast
Insect Cells
Others
Market Segmentation (by Application)
Vaccine
Therapeutics
Bioimaging
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Virus-like Particle Market
Overview of the regional outlook of the Virus-like Particle Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Virus-like Particle Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Virus-like Particle, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Virus-like Particle
1.2 Key Market Segments
1.2.1 Virus-like Particle Segment by Type
1.2.2 Virus-like Particle Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VIRUS-LIKE PARTICLE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Virus-like Particle Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Virus-like Particle Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VIRUS-LIKE PARTICLE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Virus-like Particle Product Life Cycle
3.3 Global Virus-like Particle Sales by Manufacturers (2020-2025)
3.4 Global Virus-like Particle Revenue Market Share by Manufacturers (2020-2025)
3.5 Virus-like Particle Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Virus-like Particle Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Virus-like Particle Market Competitive Situation and Trends
3.8.1 Virus-like Particle Market Concentration Rate
3.8.2 Global 5 and 10 Largest Virus-like Particle Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 VIRUS-LIKE PARTICLE INDUSTRY CHAIN ANALYSIS
4.1 Virus-like Particle Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VIRUS-LIKE PARTICLE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Virus-like Particle Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Virus-like Particle Market
5.7 ESG Ratings of Leading Companies
6 VIRUS-LIKE PARTICLE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Virus-like Particle Sales Market Share by Type (2020-2025)
6.3 Global Virus-like Particle Market Size by Type (2020-2025)
6.4 Global Virus-like Particle Price by Type (2020-2025)
7 VIRUS-LIKE PARTICLE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Virus-like Particle Market Sales by Application (2020-2025)
7.3 Global Virus-like Particle Market Size (M USD) by Application (2020-2025)
7.4 Global Virus-like Particle Sales Growth Rate by Application (2020-2025)
8 VIRUS-LIKE PARTICLE MARKET SALES BY REGION
8.1 Global Virus-like Particle Sales by Region
8.1.1 Global Virus-like Particle Sales by Region
8.1.2 Global Virus-like Particle Sales Market Share by Region
8.2 Global Virus-like Particle Market Size by Region
8.2.1 Global Virus-like Particle Market Size by Region
8.2.2 Global Virus-like Particle Market Size by Region
8.3 North America
8.3.1 North America Virus-like Particle Sales by Country
8.3.2 North America Virus-like Particle Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Virus-like Particle Sales by Country
8.4.2 Europe Virus-like Particle Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Virus-like Particle Sales by Region
8.5.2 Asia Pacific Virus-like Particle Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Virus-like Particle Sales by Country
8.6.2 South America Virus-like Particle Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Virus-like Particle Sales by Region
8.7.2 Middle East and Africa Virus-like Particle Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 VIRUS-LIKE PARTICLE MARKET PRODUCTION BY REGION
9.1 Global Production of Virus-like Particle by Region(2020-2025)
9.2 Global Virus-like Particle Revenue Market Share by Region (2020-2025)
9.3 Global Virus-like Particle Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Virus-like Particle Production
9.4.1 North America Virus-like Particle Production Growth Rate (2020-2025)
9.4.2 North America Virus-like Particle Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Virus-like Particle Production
9.5.1 Europe Virus-like Particle Production Growth Rate (2020-2025)
9.5.2 Europe Virus-like Particle Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Virus-like Particle Production (2020-2025)
9.6.1 Japan Virus-like Particle Production Growth Rate (2020-2025)
9.6.2 Japan Virus-like Particle Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Virus-like Particle Production (2020-2025)
9.7.1 China Virus-like Particle Production Growth Rate (2020-2025)
9.7.2 China Virus-like Particle Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 The Native Antigen Company
10.1.1 The Native Antigen Company Basic Information
10.1.2 The Native Antigen Company Virus-like Particle Product Overview
10.1.3 The Native Antigen Company Virus-like Particle Product Market Performance
10.1.4 The Native Antigen Company Business Overview
10.1.5 The Native Antigen Company SWOT Analysis
10.1.6 The Native Antigen Company Recent Developments
10.2 Creative BioStructure
10.2.1 Creative BioStructure Basic Information
10.2.2 Creative BioStructure Virus-like Particle Product Overview
10.2.3 Creative BioStructure Virus-like Particle Product Market Performance
10.2.4 Creative BioStructure Business Overview
10.2.5 Creative BioStructure SWOT Analysis
10.2.6 Creative BioStructure Recent Developments
10.3 Creative Biolabs
10.3.1 Creative Biolabs Basic Information
10.3.2 Creative Biolabs Virus-like Particle Product Overview
10.3.3 Creative Biolabs Virus-like Particle Product Market Performance
10.3.4 Creative Biolabs Business Overview
10.3.5 Creative Biolabs SWOT Analysis
10.3.6 Creative Biolabs Recent Developments
10.4 Leadgene Biomedical
10.4.1 Leadgene Biomedical Basic Information
10.4.2 Leadgene Biomedical Virus-like Particle Product Overview
10.4.3 Leadgene Biomedical Virus-like Particle Product Market Performance
10.4.4 Leadgene Biomedical Business Overview
10.4.5 Leadgene Biomedical Recent Developments
10.5 Abcam
10.5.1 Abcam Basic Information
10.5.2 Abcam Virus-like Particle Product Overview
10.5.3 Abcam Virus-like Particle Product Market Performance
10.5.4 Abcam Business Overview
10.5.5 Abcam Recent Developments
10.6 ACROBiosystems
10.6.1 ACROBiosystems Basic Information
10.6.2 ACROBiosystems Virus-like Particle Product Overview
10.6.3 ACROBiosystems Virus-like Particle Product Market Performance
10.6.4 ACROBiosystems Business Overview
10.6.5 ACROBiosystems Recent Developments
10.7 Gentarget
10.7.1 Gentarget Basic Information
10.7.2 Gentarget Virus-like Particle Product Overview
10.7.3 Gentarget Virus-like Particle Product Market Performance
10.7.4 Gentarget Business Overview
10.7.5 Gentarget Recent Developments
10.8 VectorBuilder
10.8.1 VectorBuilder Basic Information
10.8.2 VectorBuilder Virus-like Particle Product Overview
10.8.3 VectorBuilder Virus-like Particle Product Market Performance
10.8.4 VectorBuilder Business Overview
10.8.5 VectorBuilder Recent Developments
11 VIRUS-LIKE PARTICLE MARKET FORECAST BY REGION
11.1 Global Virus-like Particle Market Size Forecast
11.2 Global Virus-like Particle Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Virus-like Particle Market Size Forecast by Country
11.2.3 Asia Pacific Virus-like Particle Market Size Forecast by Region
11.2.4 South America Virus-like Particle Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Virus-like Particle by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Virus-like Particle Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Virus-like Particle by Type (2026-2035)
12.1.2 Global Virus-like Particle Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Virus-like Particle by Type (2026-2035)
12.2 Global Virus-like Particle Market Forecast by Application (2026-2035)
12.2.1 Global Virus-like Particle Sales (K Units) Forecast by Application
12.2.2 Global Virus-like Particle Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Virus-like Particle
1.2 Key Market Segments
1.2.1 Virus-like Particle Segment by Type
1.2.2 Virus-like Particle Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VIRUS-LIKE PARTICLE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Virus-like Particle Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Virus-like Particle Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VIRUS-LIKE PARTICLE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Virus-like Particle Product Life Cycle
3.3 Global Virus-like Particle Sales by Manufacturers (2020-2025)
3.4 Global Virus-like Particle Revenue Market Share by Manufacturers (2020-2025)
3.5 Virus-like Particle Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Virus-like Particle Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Virus-like Particle Market Competitive Situation and Trends
3.8.1 Virus-like Particle Market Concentration Rate
3.8.2 Global 5 and 10 Largest Virus-like Particle Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 VIRUS-LIKE PARTICLE INDUSTRY CHAIN ANALYSIS
4.1 Virus-like Particle Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VIRUS-LIKE PARTICLE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Virus-like Particle Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Virus-like Particle Market
5.7 ESG Ratings of Leading Companies
6 VIRUS-LIKE PARTICLE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Virus-like Particle Sales Market Share by Type (2020-2025)
6.3 Global Virus-like Particle Market Size by Type (2020-2025)
6.4 Global Virus-like Particle Price by Type (2020-2025)
7 VIRUS-LIKE PARTICLE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Virus-like Particle Market Sales by Application (2020-2025)
7.3 Global Virus-like Particle Market Size (M USD) by Application (2020-2025)
7.4 Global Virus-like Particle Sales Growth Rate by Application (2020-2025)
8 VIRUS-LIKE PARTICLE MARKET SALES BY REGION
8.1 Global Virus-like Particle Sales by Region
8.1.1 Global Virus-like Particle Sales by Region
8.1.2 Global Virus-like Particle Sales Market Share by Region
8.2 Global Virus-like Particle Market Size by Region
8.2.1 Global Virus-like Particle Market Size by Region
8.2.2 Global Virus-like Particle Market Size by Region
8.3 North America
8.3.1 North America Virus-like Particle Sales by Country
8.3.2 North America Virus-like Particle Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Virus-like Particle Sales by Country
8.4.2 Europe Virus-like Particle Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Virus-like Particle Sales by Region
8.5.2 Asia Pacific Virus-like Particle Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Virus-like Particle Sales by Country
8.6.2 South America Virus-like Particle Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Virus-like Particle Sales by Region
8.7.2 Middle East and Africa Virus-like Particle Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 VIRUS-LIKE PARTICLE MARKET PRODUCTION BY REGION
9.1 Global Production of Virus-like Particle by Region(2020-2025)
9.2 Global Virus-like Particle Revenue Market Share by Region (2020-2025)
9.3 Global Virus-like Particle Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Virus-like Particle Production
9.4.1 North America Virus-like Particle Production Growth Rate (2020-2025)
9.4.2 North America Virus-like Particle Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Virus-like Particle Production
9.5.1 Europe Virus-like Particle Production Growth Rate (2020-2025)
9.5.2 Europe Virus-like Particle Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Virus-like Particle Production (2020-2025)
9.6.1 Japan Virus-like Particle Production Growth Rate (2020-2025)
9.6.2 Japan Virus-like Particle Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Virus-like Particle Production (2020-2025)
9.7.1 China Virus-like Particle Production Growth Rate (2020-2025)
9.7.2 China Virus-like Particle Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 The Native Antigen Company
10.1.1 The Native Antigen Company Basic Information
10.1.2 The Native Antigen Company Virus-like Particle Product Overview
10.1.3 The Native Antigen Company Virus-like Particle Product Market Performance
10.1.4 The Native Antigen Company Business Overview
10.1.5 The Native Antigen Company SWOT Analysis
10.1.6 The Native Antigen Company Recent Developments
10.2 Creative BioStructure
10.2.1 Creative BioStructure Basic Information
10.2.2 Creative BioStructure Virus-like Particle Product Overview
10.2.3 Creative BioStructure Virus-like Particle Product Market Performance
10.2.4 Creative BioStructure Business Overview
10.2.5 Creative BioStructure SWOT Analysis
10.2.6 Creative BioStructure Recent Developments
10.3 Creative Biolabs
10.3.1 Creative Biolabs Basic Information
10.3.2 Creative Biolabs Virus-like Particle Product Overview
10.3.3 Creative Biolabs Virus-like Particle Product Market Performance
10.3.4 Creative Biolabs Business Overview
10.3.5 Creative Biolabs SWOT Analysis
10.3.6 Creative Biolabs Recent Developments
10.4 Leadgene Biomedical
10.4.1 Leadgene Biomedical Basic Information
10.4.2 Leadgene Biomedical Virus-like Particle Product Overview
10.4.3 Leadgene Biomedical Virus-like Particle Product Market Performance
10.4.4 Leadgene Biomedical Business Overview
10.4.5 Leadgene Biomedical Recent Developments
10.5 Abcam
10.5.1 Abcam Basic Information
10.5.2 Abcam Virus-like Particle Product Overview
10.5.3 Abcam Virus-like Particle Product Market Performance
10.5.4 Abcam Business Overview
10.5.5 Abcam Recent Developments
10.6 ACROBiosystems
10.6.1 ACROBiosystems Basic Information
10.6.2 ACROBiosystems Virus-like Particle Product Overview
10.6.3 ACROBiosystems Virus-like Particle Product Market Performance
10.6.4 ACROBiosystems Business Overview
10.6.5 ACROBiosystems Recent Developments
10.7 Gentarget
10.7.1 Gentarget Basic Information
10.7.2 Gentarget Virus-like Particle Product Overview
10.7.3 Gentarget Virus-like Particle Product Market Performance
10.7.4 Gentarget Business Overview
10.7.5 Gentarget Recent Developments
10.8 VectorBuilder
10.8.1 VectorBuilder Basic Information
10.8.2 VectorBuilder Virus-like Particle Product Overview
10.8.3 VectorBuilder Virus-like Particle Product Market Performance
10.8.4 VectorBuilder Business Overview
10.8.5 VectorBuilder Recent Developments
11 VIRUS-LIKE PARTICLE MARKET FORECAST BY REGION
11.1 Global Virus-like Particle Market Size Forecast
11.2 Global Virus-like Particle Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Virus-like Particle Market Size Forecast by Country
11.2.3 Asia Pacific Virus-like Particle Market Size Forecast by Region
11.2.4 South America Virus-like Particle Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Virus-like Particle by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Virus-like Particle Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Virus-like Particle by Type (2026-2035)
12.1.2 Global Virus-like Particle Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Virus-like Particle by Type (2026-2035)
12.2 Global Virus-like Particle Market Forecast by Application (2026-2035)
12.2.1 Global Virus-like Particle Sales (K Units) Forecast by Application
12.2.2 Global Virus-like Particle Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Virus-like Particle Market Size by Type (M USD)
Table 4. Global Virus-like Particle Market Size by Application
Table 5. Virus-like Particle Market Size Comparison by Region (M USD)
Table 6. Global Virus-like Particle Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Virus-like Particle Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Virus-like Particle Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Virus-like Particle Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virus-like Particle as of 2025)
Table 11. Global Market Virus-like Particle Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Virus-like Particle Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Virus-like Particle Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Virus-like Particle Sales by Type (K Units)
Table 27. Global Virus-like Particle Market Size by Type (M USD)
Table 28. Global Virus-like Particle Sales (K Units) by Type (2020-2025)
Table 29. Global Virus-like Particle Sales Market Share by Type (2020-2025)
Table 30. Global Virus-like Particle Market Size (M USD) by Type (2020-2025)
Table 31. Global Virus-like Particle Market Share by Type (2020-2025)
Table 32. Global Virus-like Particle Price (USD/Unit) by Type (2020-2025)
Table 33. Global Virus-like Particle Sales (K Units) by Application
Table 34. Global Virus-like Particle Market Size by Application
Table 35. Global Virus-like Particle Sales by Application (2020-2025) & (K Units)
Table 36. Global Virus-like Particle Sales Market Share by Application (2020-2025)
Table 37. Global Virus-like Particle Market Size by Application (2020-2025) & (M USD)
Table 38. Global Virus-like Particle Market Share by Application (2020-2025)
Table 39. Global Virus-like Particle Sales Growth Rate by Application (2020-2025)
Table 40. Global Virus-like Particle Sales by Region (2020-2025) & (K Units)
Table 41. Global Virus-like Particle Sales Market Share by Region (2020-2025)
Table 42. Global Virus-like Particle Market Size by Region (2020-2025) & (M USD)
Table 43. Global Virus-like Particle Market Size by Region (2020-2025)
Table 44. North America Virus-like Particle Sales by Country (2020-2025) & (K Units)
Table 45. North America Virus-like Particle Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Virus-like Particle Sales by Country (2020-2025) & (K Units)
Table 47. Europe Virus-like Particle Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Virus-like Particle Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Virus-like Particle Market Size by Region (2020-2025) & (M USD)
Table 50. South America Virus-like Particle Sales by Country (2020-2025) & (K Units)
Table 51. South America Virus-like Particle Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Virus-like Particle Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Virus-like Particle Market Size by Region (2020-2025) & (M USD)
Table 54. Global Virus-like Particle Production (K Units) by Region(2020-2025)
Table 55. Global Virus-like Particle Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Virus-like Particle Revenue Market Share by Region (2020-2025)
Table 57. Global Virus-like Particle Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Virus-like Particle Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Virus-like Particle Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Virus-like Particle Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Virus-like Particle Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. The Native Antigen Company Basic Information
Table 63. The Native Antigen Company Virus-like Particle Product Overview
Table 64. The Native Antigen Company Virus-like Particle Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. The Native Antigen Company Business Overview
Table 66. The Native Antigen Company SWOT Analysis
Table 67. The Native Antigen Company Recent Developments
Table 68. Creative BioStructure Basic Information
Table 69. Creative BioStructure Virus-like Particle Product Overview
Table 70. Creative BioStructure Virus-like Particle Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Creative BioStructure Business Overview
Table 72. Creative BioStructure SWOT Analysis
Table 73. Creative BioStructure Recent Developments
Table 74. Creative Biolabs Basic Information
Table 75. Creative Biolabs Virus-like Particle Product Overview
Table 76. Creative Biolabs Virus-like Particle Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Creative Biolabs Business Overview
Table 78. Creative Biolabs SWOT Analysis
Table 79. Creative Biolabs Recent Developments
Table 80. Leadgene Biomedical Basic Information
Table 81. Leadgene Biomedical Virus-like Particle Product Overview
Table 82. Leadgene Biomedical Virus-like Particle Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Leadgene Biomedical Business Overview
Table 84. Leadgene Biomedical Recent Developments
Table 85. Abcam Basic Information
Table 86. Abcam Virus-like Particle Product Overview
Table 87. Abcam Virus-like Particle Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Abcam Business Overview
Table 89. Abcam Recent Developments
Table 90. ACROBiosystems Basic Information
Table 91. ACROBiosystems Virus-like Particle Product Overview
Table 92. ACROBiosystems Virus-like Particle Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. ACROBiosystems Business Overview
Table 94. ACROBiosystems Recent Developments
Table 95. Gentarget Basic Information
Table 96. Gentarget Virus-like Particle Product Overview
Table 97. Gentarget Virus-like Particle Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Gentarget Business Overview
Table 99. Gentarget Recent Developments
Table 100. VectorBuilder Basic Information
Table 101. VectorBuilder Virus-like Particle Product Overview
Table 102. VectorBuilder Virus-like Particle Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. VectorBuilder Business Overview
Table 104. VectorBuilder Recent Developments
Table 105. Global Virus-like Particle Sales Forecast by Region (2026-2035) & (K Units)
Table 106. Global Virus-like Particle Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America Virus-like Particle Sales Forecast by Country (2026-2035) & (K Units)
Table 108. North America Virus-like Particle Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe Virus-like Particle Sales Forecast by Country (2026-2035) & (K Units)
Table 110. Europe Virus-like Particle Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific Virus-like Particle Sales Forecast by Region (2026-2035) & (K Units)
Table 112. Asia Pacific Virus-like Particle Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America Virus-like Particle Sales Forecast by Country (2026-2035) & (K Units)
Table 114. South America Virus-like Particle Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa Virus-like Particle Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa Virus-like Particle Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global Virus-like Particle Sales Forecast by Type (2026-2035) & (K Units)
Table 118. Global Virus-like Particle Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global Virus-like Particle Price Forecast by Type (2026-2035) & (USD/Unit)
Table 120. Global Virus-like Particle Sales (K Units) Forecast by Application (2026-2035)
Table 121. Global Virus-like Particle Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Virus-like Particle Market Size by Type (M USD)
Table 4. Global Virus-like Particle Market Size by Application
Table 5. Virus-like Particle Market Size Comparison by Region (M USD)
Table 6. Global Virus-like Particle Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Virus-like Particle Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Virus-like Particle Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Virus-like Particle Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virus-like Particle as of 2025)
Table 11. Global Market Virus-like Particle Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Virus-like Particle Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Virus-like Particle Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Virus-like Particle Sales by Type (K Units)
Table 27. Global Virus-like Particle Market Size by Type (M USD)
Table 28. Global Virus-like Particle Sales (K Units) by Type (2020-2025)
Table 29. Global Virus-like Particle Sales Market Share by Type (2020-2025)
Table 30. Global Virus-like Particle Market Size (M USD) by Type (2020-2025)
Table 31. Global Virus-like Particle Market Share by Type (2020-2025)
Table 32. Global Virus-like Particle Price (USD/Unit) by Type (2020-2025)
Table 33. Global Virus-like Particle Sales (K Units) by Application
Table 34. Global Virus-like Particle Market Size by Application
Table 35. Global Virus-like Particle Sales by Application (2020-2025) & (K Units)
Table 36. Global Virus-like Particle Sales Market Share by Application (2020-2025)
Table 37. Global Virus-like Particle Market Size by Application (2020-2025) & (M USD)
Table 38. Global Virus-like Particle Market Share by Application (2020-2025)
Table 39. Global Virus-like Particle Sales Growth Rate by Application (2020-2025)
Table 40. Global Virus-like Particle Sales by Region (2020-2025) & (K Units)
Table 41. Global Virus-like Particle Sales Market Share by Region (2020-2025)
Table 42. Global Virus-like Particle Market Size by Region (2020-2025) & (M USD)
Table 43. Global Virus-like Particle Market Size by Region (2020-2025)
Table 44. North America Virus-like Particle Sales by Country (2020-2025) & (K Units)
Table 45. North America Virus-like Particle Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Virus-like Particle Sales by Country (2020-2025) & (K Units)
Table 47. Europe Virus-like Particle Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Virus-like Particle Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Virus-like Particle Market Size by Region (2020-2025) & (M USD)
Table 50. South America Virus-like Particle Sales by Country (2020-2025) & (K Units)
Table 51. South America Virus-like Particle Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Virus-like Particle Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Virus-like Particle Market Size by Region (2020-2025) & (M USD)
Table 54. Global Virus-like Particle Production (K Units) by Region(2020-2025)
Table 55. Global Virus-like Particle Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Virus-like Particle Revenue Market Share by Region (2020-2025)
Table 57. Global Virus-like Particle Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Virus-like Particle Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Virus-like Particle Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Virus-like Particle Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Virus-like Particle Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. The Native Antigen Company Basic Information
Table 63. The Native Antigen Company Virus-like Particle Product Overview
Table 64. The Native Antigen Company Virus-like Particle Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. The Native Antigen Company Business Overview
Table 66. The Native Antigen Company SWOT Analysis
Table 67. The Native Antigen Company Recent Developments
Table 68. Creative BioStructure Basic Information
Table 69. Creative BioStructure Virus-like Particle Product Overview
Table 70. Creative BioStructure Virus-like Particle Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Creative BioStructure Business Overview
Table 72. Creative BioStructure SWOT Analysis
Table 73. Creative BioStructure Recent Developments
Table 74. Creative Biolabs Basic Information
Table 75. Creative Biolabs Virus-like Particle Product Overview
Table 76. Creative Biolabs Virus-like Particle Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Creative Biolabs Business Overview
Table 78. Creative Biolabs SWOT Analysis
Table 79. Creative Biolabs Recent Developments
Table 80. Leadgene Biomedical Basic Information
Table 81. Leadgene Biomedical Virus-like Particle Product Overview
Table 82. Leadgene Biomedical Virus-like Particle Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Leadgene Biomedical Business Overview
Table 84. Leadgene Biomedical Recent Developments
Table 85. Abcam Basic Information
Table 86. Abcam Virus-like Particle Product Overview
Table 87. Abcam Virus-like Particle Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Abcam Business Overview
Table 89. Abcam Recent Developments
Table 90. ACROBiosystems Basic Information
Table 91. ACROBiosystems Virus-like Particle Product Overview
Table 92. ACROBiosystems Virus-like Particle Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. ACROBiosystems Business Overview
Table 94. ACROBiosystems Recent Developments
Table 95. Gentarget Basic Information
Table 96. Gentarget Virus-like Particle Product Overview
Table 97. Gentarget Virus-like Particle Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Gentarget Business Overview
Table 99. Gentarget Recent Developments
Table 100. VectorBuilder Basic Information
Table 101. VectorBuilder Virus-like Particle Product Overview
Table 102. VectorBuilder Virus-like Particle Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. VectorBuilder Business Overview
Table 104. VectorBuilder Recent Developments
Table 105. Global Virus-like Particle Sales Forecast by Region (2026-2035) & (K Units)
Table 106. Global Virus-like Particle Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America Virus-like Particle Sales Forecast by Country (2026-2035) & (K Units)
Table 108. North America Virus-like Particle Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe Virus-like Particle Sales Forecast by Country (2026-2035) & (K Units)
Table 110. Europe Virus-like Particle Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific Virus-like Particle Sales Forecast by Region (2026-2035) & (K Units)
Table 112. Asia Pacific Virus-like Particle Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America Virus-like Particle Sales Forecast by Country (2026-2035) & (K Units)
Table 114. South America Virus-like Particle Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa Virus-like Particle Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa Virus-like Particle Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global Virus-like Particle Sales Forecast by Type (2026-2035) & (K Units)
Table 118. Global Virus-like Particle Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global Virus-like Particle Price Forecast by Type (2026-2035) & (USD/Unit)
Table 120. Global Virus-like Particle Sales (K Units) Forecast by Application (2026-2035)
Table 121. Global Virus-like Particle Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Virus-like Particle
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Virus-like Particle Market Size (M USD), 2025-2035
Figure 5. Global Virus-like Particle Market Size (M USD) (2020-2035)
Figure 6. Global Virus-like Particle Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Virus-like Particle Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Virus-like Particle Product Life Cycle
Figure 13. Virus-like Particle Sales Share by Manufacturers in 2025
Figure 14. Global Virus-like Particle Revenue Share by Manufacturers in 2025
Figure 15. Virus-like Particle Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Virus-like Particle Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Virus-like Particle Revenue in 2025
Figure 18. Industry Chain Map of Virus-like Particle
Figure 19. Global Virus-like Particle Market PEST Analysis
Figure 20. Global Virus-like Particle Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Virus-like Particle Market Share by Type
Figure 27. Sales Market Share of Virus-like Particle by Type (2020-2025)
Figure 28. Sales Market Share of Virus-like Particle by Type in 2025
Figure 29. Market Share of Virus-like Particle by Type (2020-2025)
Figure 30. Market Share of Virus-like Particle by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Virus-like Particle Market Share by Application
Figure 33. Global Virus-like Particle Sales Market Share by Application (2020-2025)
Figure 34. Global Virus-like Particle Sales Market Share by Application in 2025
Figure 35. Global Virus-like Particle Market Share by Application (2020-2025)
Figure 36. Global Virus-like Particle Market Share by Application in 2025
Figure 37. Global Virus-like Particle Sales Growth Rate by Application (2020-2025)
Figure 38. Global Virus-like Particle Sales Market Share by Region (2020-2025)
Figure 39. Global Virus-like Particle Market Size by Region (2020-2025)
Figure 40. North America Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Virus-like Particle Sales Market Share by Country in 2024
Figure 43. North America Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Virus-like Particle Market Size by Country in 2024
Figure 45. U.S. Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Virus-like Particle Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Virus-like Particle Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Virus-like Particle Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Virus-like Particle Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Virus-like Particle Sales Market Share by Country in 2024
Figure 53. Europe Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Virus-like Particle Market Size by Country in 2024
Figure 55. Germany Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Virus-like Particle Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Virus-like Particle Sales Market Share by Region in 2024
Figure 67. Asia Pacific Virus-like Particle Market Size by Region in 2024
Figure 68. China Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Virus-like Particle Sales and Growth Rate (K Units)
Figure 79. South America Virus-like Particle Sales Market Share by Country in 2024
Figure 80. South America Virus-like Particle Market Size and Growth Rate (M USD)
Figure 81. South America Virus-like Particle Market Size by Country in 2024
Figure 82. Brazil Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Virus-like Particle Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Virus-like Particle Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Virus-like Particle Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Virus-like Particle Market Size by Region in 2024
Figure 92. Saudi Arabia Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Virus-like Particle Production Market Share by Region (2020-2025)
Figure 103. North America Virus-like Particle Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Virus-like Particle Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Virus-like Particle Production (K Units) Growth Rate (2020-2025)
Figure 106. China Virus-like Particle Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Virus-like Particle Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Virus-like Particle Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Virus-like Particle Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Virus-like Particle Market Share Forecast by Type (2026-2035)
Figure 111. Global Virus-like Particle Sales Forecast by Application (2026-2035)
Figure 112. Global Virus-like Particle Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Virus-like Particle
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Virus-like Particle Market Size (M USD), 2025-2035
Figure 5. Global Virus-like Particle Market Size (M USD) (2020-2035)
Figure 6. Global Virus-like Particle Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Virus-like Particle Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Virus-like Particle Product Life Cycle
Figure 13. Virus-like Particle Sales Share by Manufacturers in 2025
Figure 14. Global Virus-like Particle Revenue Share by Manufacturers in 2025
Figure 15. Virus-like Particle Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Virus-like Particle Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Virus-like Particle Revenue in 2025
Figure 18. Industry Chain Map of Virus-like Particle
Figure 19. Global Virus-like Particle Market PEST Analysis
Figure 20. Global Virus-like Particle Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Virus-like Particle Market Share by Type
Figure 27. Sales Market Share of Virus-like Particle by Type (2020-2025)
Figure 28. Sales Market Share of Virus-like Particle by Type in 2025
Figure 29. Market Share of Virus-like Particle by Type (2020-2025)
Figure 30. Market Share of Virus-like Particle by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Virus-like Particle Market Share by Application
Figure 33. Global Virus-like Particle Sales Market Share by Application (2020-2025)
Figure 34. Global Virus-like Particle Sales Market Share by Application in 2025
Figure 35. Global Virus-like Particle Market Share by Application (2020-2025)
Figure 36. Global Virus-like Particle Market Share by Application in 2025
Figure 37. Global Virus-like Particle Sales Growth Rate by Application (2020-2025)
Figure 38. Global Virus-like Particle Sales Market Share by Region (2020-2025)
Figure 39. Global Virus-like Particle Market Size by Region (2020-2025)
Figure 40. North America Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Virus-like Particle Sales Market Share by Country in 2024
Figure 43. North America Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Virus-like Particle Market Size by Country in 2024
Figure 45. U.S. Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Virus-like Particle Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Virus-like Particle Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Virus-like Particle Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Virus-like Particle Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Virus-like Particle Sales Market Share by Country in 2024
Figure 53. Europe Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Virus-like Particle Market Size by Country in 2024
Figure 55. Germany Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Virus-like Particle Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Virus-like Particle Sales Market Share by Region in 2024
Figure 67. Asia Pacific Virus-like Particle Market Size by Region in 2024
Figure 68. China Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Virus-like Particle Sales and Growth Rate (K Units)
Figure 79. South America Virus-like Particle Sales Market Share by Country in 2024
Figure 80. South America Virus-like Particle Market Size and Growth Rate (M USD)
Figure 81. South America Virus-like Particle Market Size by Country in 2024
Figure 82. Brazil Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Virus-like Particle Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Virus-like Particle Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Virus-like Particle Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Virus-like Particle Market Size by Region in 2024
Figure 92. Saudi Arabia Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Virus-like Particle Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Virus-like Particle Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Virus-like Particle Production Market Share by Region (2020-2025)
Figure 103. North America Virus-like Particle Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Virus-like Particle Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Virus-like Particle Production (K Units) Growth Rate (2020-2025)
Figure 106. China Virus-like Particle Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Virus-like Particle Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Virus-like Particle Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Virus-like Particle Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Virus-like Particle Market Share Forecast by Type (2026-2035)
Figure 111. Global Virus-like Particle Sales Forecast by Application (2026-2035)
Figure 112. Global Virus-like Particle Market Share Forecast by Application (2026-2035)
